Seeking Alpha · LXEO · October 21, 2026

Lexeo Therapeutics, Inc. (LXEO) Discusses Clinical Assessment and Unmet Need in PKP2 Arrhythmogenic Cardiomyopathy Transcript

Get the app for more

Explore stock news, insights and company research.